Generic name:pancrelipase
Drug class:Digestive enzymes
Approval date: May 17, 2012
Company: Digestive Care Inc.
Treatment for: Exocrine Pancreatic Insufficiency
Medically reviewed by Drugs.com. Last updated on Aug 24, 2021.
FDA Approves Pertzye
The U.S. Food and Drug Administration (FDA) has approved Pertzye, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.
Pertzye is a unique pancreatic enzyme product containing bicarbonate-buffered enteric-coated microspheres. The Pertzye formulation was previously marketed by DCI for over a decade under the trade name Pancrecarb MS-16.
Pertzye Medication Guide
Read this Medication Guide before you start taking Pertzye and each time you get a refill. There may be new information. This information does not take the place of talking to your doctor about your medical condition or treatment.
Warnings
Pertzye may increase your chance of having a rare bowel disorder called fibrosing colonopathy. This condition is serious and may require surgery. The risk of having this condition may be reduced by following the dosing instructions that your doctor gave you.
Call your doctor right away if you have any unusual or severe:
- stomach area (abdominal) pain
- bloating
- trouble passing stool (having bowel movements)
- nausea, vomiting, or diarrhea
Take Pertzye exactly as prescribed by your doctor. Do not take more or less Pertzye than directed by your doctor.
What is Pertzye?
Pertzye is a prescription medicine used to treat people who cannot digest food normally because their pancreas does not make enough enzymes due to cystic fibrosis or other conditions.
Pertzye capsules contain a mixture of digestive enzymes including lipases, proteases and amylases from pig pancreas.
Pertzye is safe and effective in children when taken as prescribed by your doctor.
